Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2005;64(Supplement 2 ):ii65-ii68; doi:10.1136/ard.2004.031237
Copyright © 2005 BMJ Publishing Group Ltd & European League Against Rheumatism.
Annals of the Rheumatic Diseases 2005;64:ii65-ii68
© 2005 by BMJ Publishing Group Ltd & European League Against Rheumatism

REPORT

Assessment: domains and instruments

Psoriasis assessment tools in clinical trials

S R Feldman1, G G Krueger2

1 Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
2 Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, UT, USA

Correspondence to:
Correspondence to:
Dr S R Feldman
Wake Forest University School of Medicine, Department of Dermatology, Medical Center Boulevard, Winston-Salem, NC 27157-1071, USA; sfeldman{at}wfubmc.edu

In clinical practice, broad global assessments of psoriasis disease activity and its effect on patients’ quality of life are used to assess the severity of patients’ disease and their response to treatment. In clinical trials, more objective, validated instruments are required. Several such instruments have been developed and continue to be developed to provide an assessment of the severity of the skin lesions. Because a lesion’s impact on patients’ lives varies widely among patients, there has been growing recognition of the need to measure the quality of life impact of the disease along with the severity of the lesions.

Abbreviations: DLQI, Dermatology Life Quality Index; NPF-PS, National Psoriasis Foundation Psoriasis Score; PASI, Psoriasis Area and Severity Index; PGA, physician global assessment

Keywords: PASI; measurement; skin disease; quality of life


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Nijsten, T., Looman, C. W. N., Stern, R. S. (2007). Clinical Severity of Psoriasis in Last 20 Years of PUVA Study. Arch Dermatol 143: 1113-1121 [Abstract] [Full Text]  
  • Mease, P J, Antoni, C E, Gladman, D D, Taylor, W J (2005). Psoriatic arthritis assessment tools in clinical trials. Ann Rheum Dis 64: ii49-ii54 [Abstract] [Full Text]  
  • Mease, P J, Behrens, F, Boehncke, W-H, Feldman, S R, FitzGerald, O, Gladman, D D, Helliwell, P S, Nash, P, Olivieri, I, Taylor, W J, Tak, P-P (2005). Discussion: Assessment of psoriatic arthritis. Ann Rheum Dis 64: ii69-ii73 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs